Patriot Financial Group Insurance Agency’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-6
Closed – – 1136
2022
Q2
$0 Hold
6
– – ﹤0.01% 2093
2022
Q1
$0 Hold
6
– – ﹤0.01% 2142
2021
Q4
$0 Hold
6
– – ﹤0.01% 2199
2021
Q3
$1K Hold
6
– – ﹤0.01% 2060
2021
Q2
$1K Hold
6
– – ﹤0.01% 1983
2021
Q1
$1K Hold
6
– – ﹤0.01% 1886
2020
Q4
$1K Hold
6
– – ﹤0.01% 1759
2020
Q3
$1K Hold
6
– – ﹤0.01% 1555
2020
Q2
$2K Buy
+6
New +$963 ﹤0.01% 1395
2019
Q4
– Sell
-83
Closed -$2K – 1376
2019
Q3
$2K Hold
83
– – ﹤0.01% 1095
2019
Q2
$3K Hold
83
– – ﹤0.01% 1042
2019
Q1
$4K Buy
+83
New +$4.18K ﹤0.01% 896

Other funds holding INO

Patriot Financial Group Insurance Agency's INO Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Inovio Pharmaceuticals (INO) in Q3 2022, closing a stake of 6 shares.

Patriot Financial Group Insurance Agency first reported a position in INO in Q1 2019 and held it in 12 quarters. The position peaked at $4K in Q1 2019. 181 funds tracked by Wall St. Rank hold INO as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Inovio Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 6 Inovio Pharmaceuticals shares in Q3 2022.
  • Patriot Financial Group Insurance Agency first reported a position in Inovio Pharmaceuticals in Q1 2019 and held it in 12 quarters.
  • Patriot Financial Group Insurance Agency's Inovio Pharmaceuticals position peaked at $4K in Q1 2019.
  • 181 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.